Genetics/Genomics News

A genomic risk score was better than conventional risk factors at predicting incident CAD, according to new findings.

Researchers reported that a combination of SGLT1 variants appears to protect from diet-induced hyperglycemia and confers reductions in 25-year risk for HF, diabetes, obesity and death.

MUNICH — The time has come for the genetic risk score, which is simple to calculate and inexpensive to acquire, to play a larger role in primary prevention of CAD, an expert said at the European Society of Cardiology Congress.

SANTA ANA PUEBLO, N.M. — In this video, Sekar Kathiresan, MD, focuses on the reasons underlying why some individuals develop MI at a young age and strategies to identify those at risk.

The FDA announced that it has approved patisiran infusion for the treatment of patients with peripheral nerve disease caused by hereditary transthyretin-mediated amyloidosis.

A Journal of the American College of Cardiology Scientific Panel convened by the Familial Hypercholesterolemia Foundation recommended that genetic testing be the standard of care for patients with definite or probable FH.

SANTA ANA PUEBLO, N.M. — Proper identification of patients with familial hypercholesterolemia in addition to consistency with treatment and clinical procedures may benefit patients with this condition, according to a presentation at the American Society for Preventive Cardiology Congress on CVD.

About 3 million to 4 million unsuspecting Americans have a genetic risk for cancer or heart disease that could be identified through routine genomic screening, according to a paper published in Annals of Internal Medicine.

Patients with higher BMI, including young patients, had an increased risk for worse CV health, particularly increased BP and left ventricular mass index, according to an analysis published in Circulation.